| Erectile dysfunction management for the future. | |
| | |
MedLine Citation:
|
PMID: 18802198 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The field of erectile dysfunction (ED) management over time has witnessed assorted interventions to enable men to perform sexual intercourse. In recent times, major progress in ED research has led to increasingly effective treatments based on a refined knowledge of the scientific basis for penile erection. Current concepts suggest that therapeutic prospects on the horizon include novel pharmacotherapies, growth factor therapy, gene therapy, and regenerative medicine. The purpose of this review is to present the foundations for future therapies in ED management. |
| | |
Authors:
|
Arthur L Burnett |
Related Documents
:
|
22490238 - Liars, medicine, and compassion. 22279318 - How to critically appraise a clinical practice guideline. 22414018 - Study on defensive medicine practices among obstetricians and gynecologists who provide... 22557408 - Jaundice : tribal medicine. 10703548 - First policy then science: why a management unit based solely on genetic criteria canno... 10156598 - Ids technology management strategies. |
Publication Detail:
|
Type: Journal Article; Review Date: 2008-09-18 |
Journal Detail:
|
Title: Journal of andrology Volume: 30 ISSN: 1939-4640 ISO Abbreviation: J. Androl. Publication Date: 2009 Jul-Aug |
Date Detail:
|
Created Date: 2009-07-16 Completed Date: 2009-10-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8106453 Medline TA: J Androl Country: United States |
Other Details:
|
Languages: eng Pagination: 391-6 Citation Subset: IM |
Affiliation:
|
Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-2411, USA. aburnet1@jhmi.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Erectile Dysfunction
/
drug therapy,
therapy* Gene Therapy Humans Male Penile Erection Penis / innervation, physiopathology* Phosphodiesterase Inhibitors / therapeutic use Regenerative Medicine |
| Chemical | |
Reg. No./Substance:
|
0/Phosphodiesterase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an...
Next Document: Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review.